$CBNT
C-Bond Systems, Inc Stock $cbnt

$cbnt Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023066976 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$814.0K	$414.1K
YoY Change	41.89%	-23.38%
Cost Of Revenue	$346.6K	$209.1K
YoY Change	40.7%	-0.3%
Gross Profit	$467.3K	$205.0K
YoY Change	42.79%	-38.01%
Gross Profit Margin	57.42%	49.51%
Selling, General & Admin	$570.0K	$768.9K
YoY Change	-30.33%	5.04%
% of Gross Profit	121.97%	375.12%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$20.00K	$20.55K
YoY Change	-11.36%	-9.71%
% of Gross Profit	4.28%	10.02%
Operating Expenses	$582.0K	$776.8K
YoY Change	-29.72%	4.67%
Operating Profit	-$114.6K	$3.480M
YoY Change	-77.11%	-945.66%
Interest Expense	$58.69K	$166.2K
YoY Change	-86.68%	-54.13%
% of Operating Profit		4.78%
Other Income/Expense, Net	-$49.44K	$294.4K
YoY Change
Pretax Income	-$160.0K	$3.774M
YoY Change	-83.09%	-473.93%
Income Tax
% Of Pretax Income
Net Earnings	-$164.1K	$3.774M
YoY Change	-82.66%	-473.93%
Net Earnings / Revenue	-20.16%	911.54%
Basic Earnings Per Share	$0.00	$0.01
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	523.2M shares	505.0M shares
Diluted Shares Outstanding	524.7M shares	2.349B shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.130M	$1.512M
YoY Change	640.64%	518.09%
Cash & Equivalents	$1.133M	$1.512M
Short-Term Investments
Other Short-Term Assets	$30.00K	$66.95K
YoY Change	-67.49%	-38.77%
Inventory	$110.3K	$119.1K
Prepaid Expenses	$2.250K	$16.95K
Receivables	$270.8K	$133.3K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.549M	$1.831M
YoY Change	164.84%	174.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$183.9K	$79.05K
YoY Change	75.68%	-31.03%
Goodwill	$350.5K	$350.5K
YoY Change	0.0%	0.0%
Intangibles	$242.0K	$254.7K
YoY Change	-17.26%	-16.55%
Long-Term Investments	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Assets	$949.2K
YoY Change
Total Long-Term Assets	$949.2K	$870.8K
YoY Change	-18.01%	-27.9%
TOTAL ASSETS
Total Short-Term Assets	$1.549M	$1.831M
Total Long-Term Assets	$949.2K	$870.8K
Total Assets	$2.498M	$2.702M
YoY Change	43.36%	44.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$724.6K	$729.7K
YoY Change	-11.71%	-12.03%
Accrued Expenses	$406.0K	$390.8K
YoY Change	-27.35%	-23.99%
Deferred Revenue	$136.4K
YoY Change
Short-Term Debt	$1.030M	$1.031M
YoY Change	39.19%	155.22%
Long-Term Debt Due	$80.00K	$83.21K
YoY Change	-94.76%	-92.63%
Total Short-Term Liabilities	$2.824M	$2.907M
YoY Change	-33.85%	-16.01%
LONG-TERM LIABILITIES
Long-Term Debt	$60.00K	$5.550K
YoY Change	-77.19%	-97.95%
Other Long-Term Liabilities	$110.0K	$128.7K
YoY Change	-62.0%	-59.78%
Total Long-Term Liabilities	$173.1K	$134.3K
YoY Change	-68.67%	-77.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.824M	$2.907M
Total Long-Term Liabilities	$173.1K	$134.3K
Total Liabilities	$2.997M	$3.041M
YoY Change	-37.84%	-24.95%
SHAREHOLDERS EQUITY
Retained Earnings	-$59.84M	-$59.63M
YoY Change	-2.55%	-1.35%
Common Stock	$532.8K	$523.2K
YoY Change	63.57%	70.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.455M	-$454.9K
YoY Change
Total Liabilities & Shareholders Equity	$2.498M	$2.702M
YoY Change	43.36%	44.15%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$164.1K	$3.774M
YoY Change	-82.66%	-473.93%
Depreciation, Depletion And Amortization	$20.00K	$20.55K
YoY Change	-11.36%	-9.71%
Cash From Operating Activities	-$320.0K	-$622.0K
YoY Change	-16.61%	110.43%
INVESTING ACTIVITIES
Capital Expenditures	$110.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$4.043M
YoY Change
Cash From Investing Activities	-$110.0K	$4.043M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	60.00K	-1.992M
YoY Change	-79.44%	-638.34%
NET CHANGE
Cash From Operating Activities	-320.0K	-622.0K
Cash From Investing Activities	-110.0K	4.043M
Cash From Financing Activities	60.00K	-1.992M
Net Change In Cash	-370.0K	1.429M
YoY Change	302.26%	1819.05%
FREE CASH FLOW
Cash From Operating Activities	-$320.0K	-$622.0K
Capital Expenditures	$110.0K
Free Cash Flow	-$430.0K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Long Term Debt LongTermDebt		usd
CY2023Q2	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-53029
	dei	Entity Registrant Name EntityRegistrantName	C-BOND SYSTEMS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1315585
	dei	Entity Address Address Line1 EntityAddressAddressLine1	6035 South Loop East
	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77033
	dei	City Area Code CityAreaCode	832
	dei	Local Phone Number LocalPhoneNumber	649-5658
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	523233675	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1511527	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	97091	usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	80508	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	269442	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	119147	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	77446	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	66946	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	71171	usd
CY2023Q2	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	52766	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	279	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	1830894	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	515429	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79048	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	96306	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	186631	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	375412	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	254666	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	279918	usd
CY2023Q2	us-gaap	Goodwill Goodwill	350491	usd
CY2022Q4	us-gaap	Goodwill Goodwill	350491	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	6482	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	870836	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1108609	usd
CY2023Q2	us-gaap	Assets Assets	2701730	usd
CY2022Q4	us-gaap	Assets Assets	1624038	usd
CY2023Q2	cbnt	Convertible Note Payable Net Of Discount Current Portion ConvertibleNotePayableNetOfDiscountCurrentPortion	1031250	usd
CY2022Q4	cbnt	Convertible Note Payable Net Of Discount Current Portion ConvertibleNotePayableNetOfDiscountCurrentPortion	1031250	usd
CY2023Q2	cbnt	Note Payable Net Of Discount Current Portion NotePayableNetOfDiscountCurrentPortion	33209	usd
CY2022Q4	cbnt	Note Payable Net Of Discount Current Portion NotePayableNetOfDiscountCurrentPortion	1576438	usd
CY2023Q2	us-gaap	Notes Payable Current NotesPayableCurrent	50000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	729738	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	779765	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	390750	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	736393	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	15690	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	10027	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	418444	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	590632	usd
CY2023Q2	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	180000	usd
CY2022Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	22637	usd
CY2023Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	57910	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	117671	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2906991	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4864813	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	251263	usd
CY2023Q2	cbnt	Note Payable Net Of Current Portion And Discount NotePayableNetOfCurrentPortionAndDiscount	5547	usd
CY2022Q4	cbnt	Note Payable Net Of Current Portion And Discount NotePayableNetOfCurrentPortionAndDiscount	208804	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	250000	usd
CY2023Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	128721	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	258895	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	134268	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	968962	usd
CY2023Q2	us-gaap	Liabilities Liabilities	3041259	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5833775	usd
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1192427	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1037201	usd
CY2023Q2	cbnt	Temporary Equity Carrying Amount Attributable To Parent One TemporaryEquityCarryingAmountAttributableToParentOne	1635810	usd
CY2022Q4	cbnt	Temporary Equity Carrying Amount Attributable To Parent One TemporaryEquityCarryingAmountAttributableToParentOne	1803731	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4998000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4998000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	523233675	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	523233675	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	350270172	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	350270172	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	523234	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	350270	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55827561	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55141503	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-59633941	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-62693184	usd
CY2023Q2	cbnt	Total C Bond Systems Inc Shareholders Deficit TotalCBondSystemsIncShareholdersDeficit	-3283146	usd
CY2022Q4	cbnt	Total C Bond Systems Inc Shareholders Deficit TotalCBondSystemsIncShareholdersDeficit	-7201411	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	115380	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	150742	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3167766	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7050669	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2701730	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1624038	usd
CY2023Q2	us-gaap	Revenues Revenues	414055	usd
CY2022Q2	us-gaap	Revenues Revenues	540367	usd
	us-gaap	Revenues Revenues	929275	usd
	us-gaap	Revenues Revenues	1051076	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	209071	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	209704	usd
	us-gaap	Cost Of Revenue CostOfRevenue	454431	usd
	us-gaap	Cost Of Revenue CostOfRevenue	459334	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	204984	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	330663	usd
	us-gaap	Gross Profit GrossProfit	474844	usd
	us-gaap	Gross Profit GrossProfit	591742	usd
CY2023Q2	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	30046	usd
CY2022Q2	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	6618	usd
	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	42183	usd
	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	1021126	usd
CY2023Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	441181	usd
CY2022Q2	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	424714	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	868053	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	1840732	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	193263	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	132052	usd
	us-gaap	Professional Fees ProfessionalFees	380953	usd
	us-gaap	Professional Fees ProfessionalFees	446264	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	142404	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	185391	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	321304	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	390004	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	776848	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	742157	usd
	us-gaap	Operating Expenses OperatingExpenses	1570310	usd
	us-gaap	Operating Expenses OperatingExpenses	2677000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4051709	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	4051709	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	3479845	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-411494	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	2956243	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2085258	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	462581	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-234320	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	462581	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-231395	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	166189	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	362305	usd
	us-gaap	Interest Expense InterestExpense	361975	usd
	us-gaap	Interest Expense InterestExpense	610885	usd
CY2023Q2	cbnt	Interest Expenses Related Party InterestExpensesRelatedParty	1964	usd
CY2022Q2	cbnt	Interest Expenses Related Party InterestExpensesRelatedParty	1233	usd
	cbnt	Interest Expenses Related Party InterestExpensesRelatedParty	5663	usd
	cbnt	Interest Expenses Related Party InterestExpensesRelatedParty	1233	usd
CY2023Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	294428	usd
CY2022Q2	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-597858	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	94943	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-843513	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	3774273	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-1009352	usd
	us-gaap	Profit Loss ProfitLoss	3051186	usd
	us-gaap	Profit Loss ProfitLoss	-2928771	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-18640	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-10066	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-35362	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-23086	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	13618	usd
CY2022Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	17622	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	27305	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	31627	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3779295	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1016908	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3059243	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2937312	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	493056689	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	294776031	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	458283435	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	289334882	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2349380186	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	294776031	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2314606932	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	289334882	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7050669	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	300000	usd
CY2023Q1	cbnt	Common Shares Issued For Professional Fees CommonSharesIssuedForProfessionalFees	40000	usd
CY2023Q1	cbnt	Common Shares Issued For Compensation CommonSharesIssuedForCompensation	53000	usd
CY2023Q1	cbnt	Beneficial Conversion Feature On Convertible Debt BeneficialConversionFeatureOnConvertibleDebt	101400	usd
CY2023Q1	cbnt	Preferred Stock Dividends And Deemed Dividend PreferredStockDividendsAndDeemedDividend	-13687	usd
CY2023Q1	cbnt	Adjustments To Additional Paid In Capital Accretion Of Stock Based Compensation AdjustmentsToAdditionalPaidInCapitalAccretionOfStockBasedCompensation	12137	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-723087	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-7280906	usd
CY2023Q2	cbnt	Common Shares Issued For Professional Fees CommonSharesIssuedForProfessionalFees	39450	usd
CY2023Q2	cbnt	Stock Issued During Period Value Common Stock Issued For Compensation StockIssuedDuringPeriodValueCommonStockIssuedForCompensation	26000	usd
CY2023Q2	cbnt	Beneficial Conversion Feature On Convertible Debt BeneficialConversionFeatureOnConvertibleDebt	82600	usd
CY2023Q2	cbnt	Stock Issued During Period Value Common Stock Issued For Conversion Of Debt Accrued Interest And Fees StockIssuedDuringPeriodValueCommonStockIssuedForConversionOfDebtAccruedInterestAndFees	200389	usd
CY2023Q2	cbnt	Preferred Stock Dividends And Deemed Dividend PreferredStockDividendsAndDeemedDividend	-13618	usd
CY2023Q2	cbnt	Adjustments To Additional Paid In Capital Accretion Of Stock Based Compensation AdjustmentsToAdditionalPaidInCapitalAccretionOfStockBasedCompensation	4046	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	3774273	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3167766	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3979041	usd
CY2022Q1	cbnt	Common Shares Issued For Accounts Payable CommonSharesIssuedForAccountsPayable	2174	usd
CY2022Q1	cbnt	Stock Issued During Period Value Common Stock Issued For Compensation StockIssuedDuringPeriodValueCommonStockIssuedForCompensation	14250	usd
CY2022Q1	cbnt	Beneficial Conversion Feature On Convertible Debt BeneficialConversionFeatureOnConvertibleDebt	12000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	12963	usd
CY2022Q1	cbnt	Preferred Stock Dividends And Deemed Dividend PreferredStockDividendsAndDeemedDividend	-14005	usd
CY2022Q1	cbnt	Adjustments To Additional Paid In Capital Accretion Of Stock Based Compensation AdjustmentsToAdditionalPaidInCapitalAccretionOfStockBasedCompensation	42702	usd
CY2022Q1	cbnt	Beneficial Conversion Charge For Issuance Of Series B Preferred Shares For Accrued Compensation BeneficialConversionChargeForIssuanceOfSeriesBPreferredSharesForAccruedCompensation	957556	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-1919419	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-4870820	usd
CY2022Q2	cbnt	Common Shares Issued For Professional Fees CommonSharesIssuedForProfessionalFees	102000	usd
CY2022Q2	cbnt	Beneficial Conversion Feature On Convertible Debt BeneficialConversionFeatureOnConvertibleDebt	102000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	32736	usd
CY2022Q2	cbnt	Preferred Stock Dividends And Deemed Dividend PreferredStockDividendsAndDeemedDividend	-13920	usd
CY2022Q2	cbnt	Adjustments To Additional Paid In Capital Accretion Of Stock Based Compensation AdjustmentsToAdditionalPaidInCapitalAccretionOfStockBasedCompensation	6618	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	325785	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	469899	usd
CY2022Q2	cbnt	Stock Issued During Period Value Beneficial Conversion Feature Buyback Related To Debt Extinguishment StockIssuedDuringPeriodValueBeneficialConversionFeatureBuybackRelatedToDebtExtinguishment	-160993	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-1009352	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5016047	usd
	us-gaap	Profit Loss ProfitLoss	3051186	usd
	us-gaap	Profit Loss ProfitLoss	-2928771	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	41395	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	45665	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	95922	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	527219	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	29212	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	2250	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	42183	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1021126	usd
	cbnt	Stockbased Professional Fee StockbasedProfessionalFee	97817	usd
	cbnt	Stockbased Professional Fee StockbasedProfessionalFee	124050	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7716	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	462581	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-231395	usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	4051709	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	660	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	749	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-188934	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	80545	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	51196	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-20285	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	15434	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-20343	usd
	cbnt	Costs And Estimated Earnings In Excess CostsAndEstimatedEarningsInExcess	52487	usd
	cbnt	Costs And Estimated Earnings In Excess CostsAndEstimatedEarningsInExcess	-82805	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-50027	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	102	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	8040	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	77335	usd
	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties	5663	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	49812	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	34276	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	157363	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	16876	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-912997	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-799374	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	4042631	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4042631	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	275000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	250000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	200000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	175000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	175000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1792448	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	49396	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	50000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	148420	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	222750	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1715198	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	524024	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1414436	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-275350	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97091	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	519898	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1511527	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	244548	usd
	us-gaap	Interest Paid Net InterestPaidNet	199122	usd
	us-gaap	Interest Paid Net InterestPaidNet	8354	usd
	cbnt	Common Stock Issued As Prepaid For Services CommonStockIssuedAsPrepaidForServices	79450	usd
	cbnt	Common Stock Issued As Prepaid For Services CommonStockIssuedAsPrepaidForServices	102000	usd
	cbnt	Common Stock Issued For Accrued Compensation CommonStockIssuedForAccruedCompensation	78000	usd
	cbnt	Series B Preferred Stock Issued For Accrued Compensation SeriesBPreferredStockIssuedForAccruedCompensation	144000	usd
	cbnt	Series B Preferred Stock Issued For Accrued Compensation SeriesBPreferredStockIssuedForAccruedCompensation	278654	usd
	cbnt	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	27305	usd
	cbnt	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	27925	usd
	cbnt	Deemed Dividend Related To Ratchet Provision DeemedDividendRelatedToRatchetProvision	3702	usd
	cbnt	Increase In Debt Discount And Paidin Capital For Shares Issued With Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForSharesIssuedWithConvertibleDebt	45699	usd
	cbnt	Increase In Debt Discount And Paidin Capital For Warrants Issued With Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForWarrantsIssuedWithConvertibleDebt	325785	usd
	cbnt	Increase In Debt Discount And Paidin Capital For Beneficial Conversion Feature On Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForBeneficialConversionFeatureOnConvertibleDebt	469899	usd
	cbnt	Conversion Of Series C Preferred Stock To Common Stock ConversionOfSeriesCPreferredStockToCommonStock	184000	usd
	cbnt	Conversion Of Series C Preferred Stock To Common Stock ConversionOfSeriesCPreferredStockToCommonStock	114000	usd
	cbnt	Conversion Of Notes Payable To Common Stock ConversionOfNotesPayableToCommonStock	194000	usd
	cbnt	Common Stock Issued For Accouts Payable CommonStockIssuedForAccoutsPayable	2174	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span style="text-decoration:underline">NATURE OF ORGANIZATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature of Organization</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">C-Bond Systems, Inc., together with its subsidiaries (the “Company”), is a materials development company and sole owner, developer, and manufacturer of the patented C-Bond technology. The Company is engaged in the implementation of proprietary nanotechnology applications and processes to enhance properties of strength, functionality, and sustainability of brittle material systems. The Company’s primary focus is in the multi-billion-dollar glass and window film industry with target markets in the United States and internationally. The Company operates in two divisions: C-Bond Transportation Solutions and Patriot Glass Solutions. C-Bond Transportation Solutions sold a windshield strengthening, water repellent solution called C-Bond nanoShield™ through May 8, 2023, the date that the nanoShield product line and related technologies were sold (see Note 16). Patriot Glass Solutions sells multi-purpose glass strengthening primer and window film mounting solutions, including C-Bond BRS, a ballistic-resistant film system, and C-Bond Secure, a forced entry system.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 30, 2021, the Company entered into a Share Exchange Agreement and Plan of Reorganization (the “Exchange Agreement”) with (i) Mobile Tint LLC, a Texas limited liability company doing business as A1 Glass Coating (“Mobile”), (ii) the sole member of Mobile (the “Mobile Shareholder”), and (iii) Michael Wanke as the Representative of the Mobile Shareholder. Pursuant to the Exchange Agreement, the Company agreed to acquire 80% of Mobile’s units, representing 80% of Mobile’s issued and outstanding capital stock (the “Mobile Shares”). On July 22, 2021, the Company closed the Exchange Agreement and acquired 80% of the Mobile Shares. The Mobile Shares were exchanged for 28,021,016 restricted shares of the Company’s common stock in an amount equal to $800,000, divided by the average of the closing prices of the Company’s common stock during the 30-day period immediately prior to the closing. Two years after closing, the Company has the option to acquire the remaining 20% of Mobile’s issued and outstanding membership interests in exchange for a number of shares of the Company’s common stock equal to 300% of Mobile’s average EBIT value, divided by the price of the Company’s common stock as defined in the Exchange Agreement (the “Additional Closing”). Mobile provides quality window tint solutions for auto, home, and business owners across Texas, specializing in automotive window tinting, residential window film, and commercial window film that stop harmful UV rays from passing through its window films for reduced glare, comfortable temperatures, and lower energy bills. Mobile also carries products that offer forced-entry protection and films that protect glass from scratches, graffiti, other types of vandalism, and even bullets, including C-Bond BRS and C-Bond Secure products. As part of the transaction, Mobile’s owner-operator, Mr. Wanke, joined the Company as President of its Patriot Glass Solutions division.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 8, 2023, the Company entered into an Asset Purchase Agreement (“APA”) with Apex Protect GPS, LLC (the “Buyer”), whereby the Company sold its C-Bond nanoShield™ business, including intangible assets, intellectual property, work in process, furniture, fixtures, equipment, inventory and other physical assets of the Company’s C-Bond nanoShield division (the “Assets”) to the Buyer. Accordingly, the Company assigned, transferred and delivered to the Buyer, free and clear of all liens, all of the Assets. Following the Closing, the Parties entered into an Assignment and Agreement to Re-Execute (“Assignment”) on June 15, 2023, by and among the Company (“Seller”); Apex Protect GPS, LLC, (“Assignor”) and CB Nanoshield, LLC, (“Assignee”), whereby the Assignor assigned all its right to the (i) APA; (ii) Bill of Sale (iii) IP Agreements; and (iv) and any memorandums, schedules and exhibits related to the foregoing to Assignee. The Seller and Assignee also entered into a Lease and Assignment and Assumption Agreement on June 15, 2023 (the “Assignment Agreement”), wherein the Seller assigned to Assignee, and Assignee took assignment from the Seller, of the lease for the premises located at 6035 South Loop East, Houston, Texas 77033 (the “Lease”) pursuant to the Assignment Agreement (See Note 16).</span></p>
CY2021Q2	cbnt	Minority Interest Ownership Percentage MinorityInterestOwnershipPercentage	0.80	pure
CY2021Q2	cbnt	Issued And Outstanding Percent IssuedAndOutstandingPercent	0.80	pure
CY2021Q3	cbnt	Minority Interest Ownership Percentage MinorityInterestOwnershipPercentage	0.80	pure
CY2021Q3	cbnt	Restricted Shares Of Common Stock RestrictedSharesOfCommonStock	28021016	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend	800000	usd
CY2021Q3	cbnt	Issued And Outstanding Interest IssuedAndOutstandingInterest	0.20	pure
CY2021Q3	cbnt	Common Stock Percentage CommonStockPercentage	3	pure
CY2021Q3	cbnt	Consolidated Financial Statements Percentage ConsolidatedFinancialStatementsPercentage	0.80	pure
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Estimates during the six months ended June 30, 2023 and 2022 include estimates for allowance for doubtful accounts on accounts receivable, the estimates for obsolete or slow moving inventory, estimates used in the calculation of progress towards completion on uncompleted jobs, the useful life of property and equipment, assumptions used in assessing impairment of long-term assets, the estimate of the fair value lease liability and related right of use asset, the valuation of redeemable and mandatorily redeemable preferred stock, the value of beneficial conversion features and deemed dividends, the valuation allowances for deferred tax assets, and the fair value of non-cash equity transactions.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks and Uncertainties</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. On June 30, 2023, the Company had cash in bank in excess of FDIC insured levels of $1,157,360. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits. Any material loss that the Company may experience in the future could have an adverse effect on its ability to pay its operational expenses or make other payments and may require the Company to move its cash to other high quality financial institutions.<b> </b>Currently, the Company is reviewing its bank relationships in order to mitigate its risk to ensure that its exposure is limited or reduced to the FDIC protection limits.</span></p>
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	1157360	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Derivative Financial Instruments</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had certain financial instruments that were embedded derivatives. The Company evaluated all its financial instruments to determine if those contracts or any potential embedded components of those contracts qualify as derivatives to be separately accounted for in accordance with ASC 815-10-05-4, <i>Derivatives and Hedging</i> and 815-40, <i>Contracts in Entity’s Own Equity</i>. This accounting treatment requires that the carrying amount of any embedded derivatives be recorded at fair value at issuance and marked-to-market at each balance sheet date. In the event that the fair value is recorded as a liability, as is the case with the Company, the change in the fair value during the period is recorded as either other income or expense. Upon conversion, exercise or repayment, the respective derivative liability is marked to fair value at the conversion, repayment or exercise date and then the related fair value amount is reclassified to other income or expense as part of gain or loss on extinguishment.</span></p>
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	26648	usd
	cbnt	Beneficial Conversion Feature BeneficialConversionFeature	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Beneficial Conversion Feature</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible debt includes conversion terms that are considered in the money compared to the market price of the stock on the date of the related agreement. The Company calculates the beneficial conversion feature and records a debt discount with the amount being amortized to interest expense over the term of the note.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	5577	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	6860	usd
	cbnt	Costs Incurred CostsIncurred	0	usd
	cbnt	Costs Incurred CostsIncurred	0	usd
	cbnt	Research And Development Costs ResearchAndDevelopmentCosts	10986	usd
	cbnt	Research And Development Costs ResearchAndDevelopmentCosts	55829	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3779295	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1016908	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3059243	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2937312	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	493056689	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	294776031	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	458283435	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	289334882	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3779295	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1016908	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3059243	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2937312	usd
CY2023Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	13618	usd
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	27305	usd
CY2023Q2	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	52618	usd
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	102639	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3845531	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1016908	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3189187	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2937312	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	493056689	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	294776031	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	458283435	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	289334882	shares
CY2023Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1145833333	shares
CY2023Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1145833333	shares
CY2023Q2	cbnt	Series B Preferred Shares SeriesBPreferredShares	324240164	shares
CY2023Q2	cbnt	Series B Preferred Shares SeriesBPreferredShares	324240164	shares
CY2023Q2	cbnt	Series C Preferred Shares SeriesCPreferredShares	386250000	shares
CY2023Q2	cbnt	Series C Preferred Shares SeriesCPreferredShares	386250000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2349380186	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	294776031	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2314606932	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	289334882	shares
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1898769195	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	572414717	shares
CY2023Q2	cbnt	Finite Lived Intangible Assets Net1 FiniteLivedIntangibleAssetsNet1	254666	usd
CY2023Q2	us-gaap	Accounts Receivable Gross AccountsReceivableGross	106780	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	304964	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	26272	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	35522	usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	80508	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	269442	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1501	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	119147	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	75945	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	119147	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	77446	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	119147	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	77446	usd
CY2022Q4	cbnt	Finite Lived Intangible Assets Net1 FiniteLivedIntangibleAssetsNet1	279918	usd
CY2023Q2	us-gaap	Goodwill Goodwill	350491	usd
CY2022Q4	us-gaap	Goodwill Goodwill	350491	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	25252	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	25252	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.025
CY2022Q2	cbnt	Deemed Dividents DeemedDividents	3702	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	139397	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	263930	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	60349	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	167624	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79048	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	96306	usd
CY2023Q2	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2023Q2	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	212516	usd
CY2022Q4	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	212516	usd
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y
	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	40000	usd
CY2022	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	40000	usd
CY2023Q2	us-gaap	Finite Lived Trade Names Gross FiniteLivedTradeNamesGross	100000	usd
CY2022Q4	us-gaap	Finite Lived Trade Names Gross FiniteLivedTradeNamesGross	100000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	352516	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	352516	usd
CY2023Q2	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	97850	usd
CY2022Q4	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	72598	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	50503	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	50503	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	50503	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3157	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	154666	usd
CY2021Q4	cbnt	Original Issue Discount Rate OriginalIssueDiscountRate	0.10	pure
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	825000	usd
CY2021Q4	cbnt	Warrant To Purchase Shares Of Common Stock WarrantToPurchaseSharesOfCommonStock	16500000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.05
CY2021Q4	cbnt	Conversion Shares Percent conversionSharesPercent	0.50	pure
CY2021Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	680000	usd
CY2021Q4	cbnt	Original Issued Discount Rate OriginalIssuedDiscountRate	75000	usd
CY2021Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two And Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwoAndThree	60000	usd
CY2021Q4	us-gaap	Legal Fees LegalFees	10000	usd
	cbnt	Future Financings Percentage FutureFinancingsPercentage	0.30	pure
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	33000000	shares
CY2022Q2	cbnt	Original Issue Discount Rate OriginalIssueDiscountRate	0.10	pure
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	825000	usd
CY2022Q2	us-gaap	Long Term Debt Maturity Date LongTermDebtMaturityDate	2022-10-15
CY2022Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.04	pure
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.0125
CY2022Q2	cbnt	Conversion Price Per Share ConversionPricePerShare	0.00875
CY2022Q4	cbnt	Penalty Amount PenaltyAmount	206250	usd
CY2022Q4	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	0.25	pure
CY2022Q4	us-gaap	Interest And Debt Expense InterestAndDebtExpense	206250	usd
CY2022Q4	us-gaap	Long Term Debt Percentage Bearing Variable Interest Rate LongTermDebtPercentageBearingVariableInterestRate	0.18	pure
	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	1031250	usd
CY2022	us-gaap	Debt Instrument Issued Principal DebtInstrumentIssuedPrincipal	1031250	usd
CY2022Q2	cbnt	Warrant To Purchase Shares Of Common Stock WarrantToPurchaseSharesOfCommonStock	16500000	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.025
CY2023Q2	cbnt	Aggregate Noncash Debt Discount AggregateNoncashDebtDiscount	680000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.011
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.011
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price Decrease DebtInstrumentConvertibleConversionPriceDecrease	0.009
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.009
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.009
CY2022Q3	cbnt	Current Exercise Price CurrentExercisePrice	0.011
CY2022Q3	cbnt	New Exercise Price NewExercisePrice	0.009
CY2022Q3	cbnt	Deemed Dividents DeemedDividents	733	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	104250	usd
CY2022Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	100000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two And Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwoAndThree	4250	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.22	pure
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	64250	usd
CY2022Q4	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	60000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two And Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwoAndThree	4250	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.22	pure
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	54250	usd
CY2023Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	50000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two And Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwoAndThree	4250	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.22	pure
CY2022Q4	us-gaap	Debtor In Possession Financing Interest Rate On Borrowings Outstanding DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding	1.15	pure
CY2022Q4	us-gaap	Debtor In Possession Financing Interest Rate On Borrowings Outstanding DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding	1.20	pure
CY2023Q1	us-gaap	Debtor In Possession Financing Interest Rate On Borrowings Outstanding DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding	1.25	pure
	cbnt	Conversion Of Percentage ConversionOfPercentage	0.65	pure
CY2022Q4	cbnt	Aggregate Debt Premium AggregateDebtPremium	90731	usd
CY2022Q4	cbnt	Aggregate Debt Premium AggregateDebtPremium	90731	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	119943	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	119943	usd
CY2023Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2627	usd
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	516875	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	173095	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	83138	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1031250	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1199750	usd
CY2022Q4	cbnt	Add Put Premium AddPutPremium	90731	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	7968	usd
CY2023Q2	cbnt	Convertible Note Payable Net ConvertibleNotePayableNet	1031250	usd
CY2022Q4	cbnt	Convertible Note Payable Net ConvertibleNotePayableNet	1282513	usd
CY2023Q2	cbnt	Less Current Portion Of Convertible Note Payable LessCurrentPortionOfConvertibleNotePayable	1031250	usd
CY2022Q4	cbnt	Less Current Portion Of Convertible Note Payable LessCurrentPortionOfConvertibleNotePayable	1031250	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	251263	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	19933	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	1899380	usd
CY2023Q2	cbnt	Note Payable Ppp Note NotePayable_PppNote	18823	usd
CY2022Q4	cbnt	Note Payable Ppp Note NotePayable_PppNote	18823	usd
CY2023Q2	cbnt	Total Notes Payable TotalNotesPayable	38756	usd
CY2022Q4	cbnt	Total Notes Payable TotalNotesPayable	1918203	usd
CY2022Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	132961	usd
CY2023Q2	us-gaap	Other Notes Payable OtherNotesPayable	38756	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	1785242	usd
CY2023Q2	cbnt	Less Current Portion Of Notes Payable LessCurrentPortionOfNotesPayable	-33209	usd
CY2022Q4	cbnt	Less Current Portion Of Notes Payable LessCurrentPortionOfNotesPayable	-1576438	usd
CY2023Q2	cbnt	Notes Payable Longterm NotesPayableLongterm	5547	usd
CY2022Q4	cbnt	Notes Payable Longterm NotesPayableLongterm	208804	usd
CY2018Q4	cbnt	Proceeds From Notes Payables ProceedsFromNotesPayables	400000	usd
CY2018Q4	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.18	pure
	cbnt	Loan Agreement Description LoanAgreementDescription	In the event that the Company’s accounts receivable balance plus inventory balance is less than paid principal balance of the Note as of December 31, 2018, the Company shall have 45 days (through and until February 15, 2019) to cure such violation and an establish accounts receivable plus inventory equal to the unpaid principal balance of the Note. Commencing March 31, 2019 and at all times thereafter through the remainder of the commitment period and for so long thereafter as there is any amount still due and owing under the Note, the Company must maintain an accounts receivable balances plus inventory such that the outstanding principal borrowed by Company under the Loan Agreement and Note is less than or equal to eighty five percent (85%) of accounts receivable plus fifty percent (50%) of inventory, all as measured at the same point in time.
CY2023Q2	cbnt	Note Balance Due NoteBalanceDue	400000	usd
	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.18	pure
CY2023Q2	cbnt	Company Agreed CompanyAgreed	200000	usd
CY2023Q2	us-gaap	Shares Issued SharesIssued	22000000	shares
CY2023Q2	us-gaap	Cash Cash	200000	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	317293	usd
CY2023Q2	cbnt	Principal Amount PrincipalAmount	68000	usd
CY2023Q2	cbnt	Fair Value Measurement FairValueMeasurement	132000	usd
CY2023Q2	cbnt	Interest Due InterestDue	317293	usd
CY2023Q2	cbnt	Principal Amount principalAmount	197500	usd
CY2022Q1	cbnt	Accrued Interest Payables AccruedInterestPayables	6217	usd
CY2022Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	195000	usd
CY2022Q2	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q2	cbnt	Original Issue Discount And Investor Legal Fees OriginalIssueDiscountAndInvestorLegalFees	19000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	148420	usd
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1750000	shares
CY2022Q2	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	21060	usd
CY2022Q2	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.08	pure
CY2022Q2	us-gaap	Debt Instrument Description DebtInstrumentDescription	GS Capital shall have the right at any time following an Event of Default to convert all or any part of the outstanding and unpaid principal, interest, penalties, and all other amounts under this Note at a conversion price of $0.011, subject to adjustment as defined in the GS Capital Note. The Company did not calculate a beneficial conversion feature since the GS Capital Note is contingently convertible upon default on the GS Capital Note. As of December 31, 2022, the Company is not in default on this note. In the event that following the Issue Date the closing trading price of the Company’s common stock is then being traded is below $0.011 per share for more than ten consecutive trading days, then the conversion price shall be equal to $0.004 per share. The GS Capital Note contains conversion limitations providing that a holder thereof may not convert the Note to the extent (but only to the extent) that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice. Events of default include, amongst other items, failure to pay principal or interest, bankruptcy, delisting of the Company’s stock, financial statement restatements, or if the Company effectuates a reverse split. Upon the occurrence of any event of default, the GS Capital Note shall become immediately and automatically due and payable and the Company shall pay to GS Capital, in full satisfaction of its obligations hereunder, an amount equal to: (a) the then outstanding principal amount of this note plus (b) accrued and unpaid interest on the unpaid principal amount of this note to the date of payment (the “mandatory prepayment date”) plus (y) default interest, if any, multiplied by 120%. On December 15, 2022, the Company and GS Capital entered into a letter agreement to extend the due date of the GS Capital June 2022 note by 60 days.
CY2022Q4	cbnt	Company Paid CompanyPaid	53512	usd
CY2023Q2	cbnt	Company Paid CompanyPaid	79488	usd
CY2023Q2	us-gaap	Shares Issued SharesIssued	21371481	shares
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	62000	usd
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	62000	usd
CY2023Q2	cbnt	Accrued Interest AccruedInterest	4139	usd
CY2023Q2	cbnt	Accrued Interest AccruedInterest	4139	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2023Q2	cbnt	Principal Balance Due PrincipalBalanceDue	0	usd
CY2022Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	195000	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q3	cbnt	Original Issue Discount And Investor Legal Fees OriginalIssueDiscountAndInvestorLegalFees	19000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	158920	usd
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2600000	shares
CY2022Q3	us-gaap	Shares Issued SharesIssued	998008	shares
CY2022Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	34606	usd
CY2022Q3	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	21060	usd
CY2022Q3	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.08	pure
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.011
CY2022Q3	us-gaap	Class Of Warrant Or Right Reason For Issuing To Nonemployees ClassOfWarrantOrRightReasonForIssuingToNonemployees	In the event that following the Issue Date the closing trading price of the Company’s common stock is then being traded is below $0.011 per share for more than ten consecutive trading days, then the conversion price shall be equal to $0.004 per share. The July 2022 Note contains conversion limitations providing that a holder thereof may not convert the Note to the extent (but only to the extent) that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice.
CY2022	cbnt	Paid Principal PaidPrincipal	34120	usd
	cbnt	Paid Principal PaidPrincipal	160880	usd
CY2022Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	160880	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	6441	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	195000	usd
CY2022Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	176000	usd
CY2022Q3	cbnt	Original Issue Discount And Investor Legal Fees OriginalIssueDiscountAndInvestorLegalFees	19000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	158920	usd
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3300000	shares
CY2022Q3	us-gaap	Shares Issued SharesIssued	773626	shares
	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	The September Commitment Shares and the placement agent shares were recorded as a debt discount of $30,326 based on the relative fair value method to be amortized over the life of the Note. Additionally, the September 2022 Note is convertible into common shares upon an event of default at an initial effective conversion price which was lower than the fair value of common shares based on the quoted closing price of the Company’s common stock on the measurement date. Principal and interest payments shall be made in 9 installments of $23,400 each beginning on the 120th-day anniversary following the issue date and continuing thereafter each 30 days for eight months. The September 2022 Note matures 12 months after issuance and bears interest at a rate of 8% per annum. GS Capital shall have the right at any time following an Event of Default to convert all or any part of the outstanding and unpaid principal, interest, penalties, and all other amounts under the September 2022 Note at a conversion price of $0.009, subject to adjustment as defined in the Note. The Company did not calculate a beneficial conversion feature since the GS Capital July 2022 Note is contingently convertible upon a default on the September 2022 Note. As of December 31, 2022, the Company is not in default on this note. In the event that following the Issue Date the closing trading price of the Company’s common stock is then being traded is below $0.009 per share for more than ten consecutive trading days, then the conversion price shall be equal to $0.0032 per share. The September 2022 Note contains conversion limitations providing that a holder thereof may not convert the Note to the extent (but only to the extent) that, if after giving effect to such conversion, the holder or any of its affiliates would beneficially own in excess of 4.99% of the outstanding shares of the Company’s common stock immediately after giving effect to such conversion or exercise. A holder may increase or decrease its beneficial ownership limitation upon notice to the Company provided that in no event such limitation exceeds 9.99%, and that any increase shall not be effective until the 61st day after such notice. On December 15, 2022, the Company and GS Capital entered into a letter agreement to extend the due date of the GS Capital September 2022 note by 60 days. Specifically, the maturity date of the GS Capital September 2022 note was extended to November 6, 2023 and the next payment due date was extended to March 6, 2023. In May 2023, the GS Capital September Note and all accrued interest due was paid in full (See Note 16). On June 30, 2023, the principal balance due on the GS Capital September 2022 Note and accrued interest payable amounted to $0. On December 31, 2022, the principal balance due on the GS Capital September 2022 Note amounted to $195,000 and accrued interest payable amounted to $5,001.
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	0	usd
CY2022Q4	cbnt	Common Stock commonStock	112500	shares
CY2022	cbnt	Loss On Debt Extinguishment lossOnDebtExtinguishment	112500	usd
CY2021Q2	cbnt	Secured Promissory Note Amount SecuredPromissoryNoteAmount	500000	usd
CY2021Q2	cbnt	Annual Accrued Interest Percentage AnnualAccruedInterestPercentage	0.08	pure
CY2022	cbnt	Promissory Note Amounted PromissoryNoteAmounted	65863	usd
CY2021Q3	cbnt	Capital Lease Amount CapitalLeaseAmount	95013	usd
CY2023Q2	cbnt	Notes Payable Vehicles And Equipment Loans NotesPayableVehiclesAndEquipmentLoans	19933	usd
CY2022Q4	cbnt	Notes Payable Vehicles And Equipment Loans NotesPayableVehiclesAndEquipmentLoans	39513	usd
CY2022Q4	cbnt	Received Net Proceed ReceivedNetProceed	200000	usd
CY2022Q4	cbnt	Outstanding Interest Rate Percentage OutstandingInterestRatePercentage	0.08	pure
CY2022Q4	cbnt	Principal Amount PrincipalAmount	200000	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	175000	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	175000	usd
CY2023Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.08	pure
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	93295	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	110344	usd
CY2023Q2	cbnt	Operating Leases Future Minimum Payment Due In Four Years OperatingLeasesFutureMinimumPaymentDueInFourYears	33209	usd
CY2023Q2	cbnt	Operating Leases Future Minimum Payment Due In Four And Five Years OperatingLeasesFutureMinimumPaymentDueInFourAndFiveYears	5547	usd
CY2023Q2	cbnt	Operating Leases Future Minimum Payment Due Thereafter OperatingLeasesFutureMinimumPaymentDueThereafter	38756	usd
CY2023Q2	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	400	pure
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	957556	usd
CY2022Q2	cbnt	Stated Redemption Value StatedRedemptionValue	102000	usd
	us-gaap	Dividends Cash DividendsCash	16079	usd
	us-gaap	Dividends Cash DividendsCash	18078	usd
CY2023Q2	cbnt	Stated Value StatedValue	1545000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	300000
CY2023Q1	cbnt	Cash Payments CashPayments	275000	usd
CY2023Q1	cbnt	Conversion Conversion	25000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	53000	shares
CY2023Q1	cbnt	Accrued Compensations AccruedCompensations	9636364	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	500000	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	14250	usd
CY2022Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0285
CY2023Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	2500000	shares
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	26000	usd
CY2023Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.0104
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	42183	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	63570	usd
	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	16970120	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.119
	cbnt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Shares Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsSharesVestedNumberOfShares	-2000000	shares
	cbnt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Shares Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsSharesVestedWeightedAverageGrantDateFairValue	0.021
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	14970120	shares
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.132
CY2022Q1	cbnt	Conversion Of Stock Shares Issued ConversionOfStockSharesIssued	823529	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	823529	shares
CY2022Q1	cbnt	Amortization Of Debt Discount AmortizationOfDebtDiscount	12963	usd
CY2022Q2	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1750000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1750000	shares
CY2022Q2	us-gaap	Debt Securities DebtSecurities	32736	usd
CY2023Q2	us-gaap	Shares Issued SharesIssued	21371481	shares
CY2023Q2	cbnt	Conversion Principal ConversionPrincipal	62000	usd
CY2023Q2	cbnt	Conversion Principal ConversionPrincipal	62000	usd
CY2023Q2	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	4139	usd
CY2023Q2	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	4139	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2023Q2	us-gaap	Legal Fees LegalFees	2250	usd
CY2023Q2	us-gaap	Shares Issued SharesIssued	22000000	shares
CY2023Q2	us-gaap	Settlement Assets Current SettlementAssetsCurrent	200000	usd
CY2023Q2	us-gaap	Financing Receivable Accrued Interest Modified FinancingReceivableAccruedInterestModified	317293	usd
CY2023Q2	cbnt	Issued Share IssuedShare	22000000	shares
CY2023Q2	us-gaap	Shortterm Debt Fair Value ShorttermDebtFairValue	132000	usd
CY2023Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.006
CY2023Q2	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	68000	usd
CY2023Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	200000	usd
CY2023Q2	cbnt	Fair Value Measurement FairValueMeasurement	132000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0	usd
	cbnt	Voting Percentage VotingPercentage	0.10	pure
	cbnt	Fair Market Percentage FairMarketPercentage	1.10	pure
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	50000000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	11445698	shares
	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	29451070	shares
	cbnt	Reported Revenue ReportedRevenue	102569	usd
	cbnt	Bad Debt Expenses BadDebtExpenses	102569	usd
CY2021Q3	us-gaap	Bankruptcy Claims Amount Of Claims Settled BankruptcyClaimsAmountOfClaimsSettled	16000	usd
CY2023Q2	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	18250	usd
CY2022Q4	us-gaap	Compensated Absences Liability CompensatedAbsencesLiability	18250	usd
CY2021Q1	cbnt	Bonus To Officers And Employee BonusToOfficersAndEmployee	330000	usd
CY2021Q3	us-gaap	Salaries And Wages SalariesAndWages	240000	usd
CY2021Q3	cbnt	Base Salaries Percentage BaseSalariesPercentage	0.50	pure
	cbnt	Base Salary Bonus Percentage BaseSalaryBonusPercentage	0.50	pure
CY2022Q4	cbnt	Aggregate Amount AggregateAmount	160000	usd
CY2022Q4	us-gaap	Other Commitments Description OtherCommitmentsDescription	This bonus will be paid 10% in cash ($16,000) which was paid in December 2022 and 90% in equity amounting to $144,000 which as of December 31, 2022 had been accrued and as of December 31, 2022, was included in accrued compensation on the accompanying consolidated balance sheet.
CY2023Q1	cbnt	Bonus Owed Executive Officers BonusOwedExecutiveOfficers	144000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Shares PreferredStockDividendsShares	144	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.85
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	1157360	usd
	cbnt	Number Of Customer NumberOfCustomer	1	pure
	cbnt	Customer Accounted Sales Percentage CustomerAccountedSalesPercentage	0.148	pure
	cbnt	Number Of Customers NumberOfCustomers	6	pure
	cbnt	Number Of Suppliers NumberOfSuppliers	5	pure
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2023Q2	cbnt	Revenue Revenue	414055	usd
CY2022Q2	cbnt	Revenue Revenue	540367	usd
	cbnt	Revenue Revenue	929275	usd
	cbnt	Revenue Revenue	1051076	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20545	usd
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22755	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	41395	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45665	usd
CY2023Q2	us-gaap	Interest Expense Other InterestExpenseOther	168153	usd
CY2022Q2	us-gaap	Interest Expense Other InterestExpenseOther	363538	usd
	us-gaap	Interest Expense Other InterestExpenseOther	367638	usd
	us-gaap	Interest Expense Other InterestExpenseOther	612118	usd
CY2023Q2	us-gaap	Net Income Loss Allocated To General Partners NetIncomeLossAllocatedToGeneralPartners	3774273	usd
CY2022Q2	us-gaap	Net Income Loss Allocated To General Partners NetIncomeLossAllocatedToGeneralPartners	-1009352	usd
	us-gaap	Net Income Loss Allocated To General Partners NetIncomeLossAllocatedToGeneralPartners	3051186	usd
	us-gaap	Net Income Loss Allocated To General Partners NetIncomeLossAllocatedToGeneralPartners	-2928771	usd
CY2023Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	79048	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	96306	usd
	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	929275	usd
	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	1051076	usd
CY2020	us-gaap	Payments For Rent PaymentsForRent	4444	usd
	us-gaap	Payments For Rent PaymentsForRent	4577	usd
	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	On May 12, 2021 and effective June 1, 2021
CY2021Q2	us-gaap	Lease Cost LeaseCost	5283	usd
	cbnt	Lease Term LeaseTerm	P60M
	us-gaap	Payments For Rent PaymentsForRent	5600	usd
CY2021Q3	cbnt	Lease Agreemen Description LeaseAgreemenDescription	the Company entered into a 48-month lease agreement for the lease of office equipment under a non-cancelable operating lease through September 2025.
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	365	usd
CY2022Q1	cbnt	Lease Agreemen Description LeaseAgreemenDescription	the Company entered into a 36-month lease agreement for the lease of a vehicle under a non-cancelable operating lease through January 2025.
CY2022Q1	us-gaap	Payments For Rent PaymentsForRent	788	usd
	cbnt	Lease And Rental Expenses LeaseAndRentalExpenses	67901	usd
	cbnt	Lease And Rental Expenses LeaseAndRentalExpenses	79473	usd
CY2023Q2	cbnt	Office Leases Right Of Use Assets OfficeLeasesRightOfUseAssets	279162	usd
CY2022Q4	cbnt	Office Leases Right Of Use Assets OfficeLeasesRightOfUseAssets	480293	usd
CY2023Q2	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	92531	usd
CY2022Q4	us-gaap	Deferred Costs Leasing Accumulated Amortization DeferredCostsLeasingAccumulatedAmortization	104881	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	186631	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	375412	usd
CY2023Q2	cbnt	Lease Liabilities Related To Office Leases Right Of Use Assets LeaseLiabilitiesRelatedToOfficeLeasesRightOfUseAssets	186631	usd
CY2022Q4	cbnt	Lease Liabilities Related To Office Leases Right Of Use Assets LeaseLiabilitiesRelatedToOfficeLeasesRightOfUseAssets	376566	usd
CY2023Q2	cbnt	Less Current Portion Of Lease Liabilities LessCurrentPortionOfLeaseLiabilities	-57910	usd
CY2022Q4	cbnt	Less Current Portion Of Lease Liabilities LessCurrentPortionOfLeaseLiabilities	-117671	usd
CY2023Q2	cbnt	Lease Liabilities Longterm LeaseLiabilitiesLongterm	128721	usd
CY2022Q4	cbnt	Lease Liabilities Longterm LeaseLiabilitiesLongterm	258895	usd
CY2023Q2	cbnt	Operating Leases Future Minimum Payments Due Currents OperatingLeasesFutureMinimumPaymentsDueCurrents	76654	usd
CY2023Q2	cbnt	Operating Leases Future Minimum Payments Due In Two Year OperatingLeasesFutureMinimumPaymentsDueInTwoYear	72714	usd
CY2023Q2	cbnt	Operating Leases Future Minimum Payments Due In Three Year OperatingLeasesFutureMinimumPaymentsDueInThreeYear	67200	usd
CY2023Q2	cbnt	Operating Leases Future Minimum Payments Due In Four Year OperatingLeasesFutureMinimumPaymentsDueInFourYear	5600	usd
CY2023Q2	cbnt	Total Minimum Noncancelable Operating Lease Payments TotalMinimumNoncancelableOperatingLeasePayments	222168	usd
CY2023Q2	cbnt	Discount To Fair Value DiscountToFairValue	35537	usd
CY2023Q2	cbnt	Total Lease Liability TotalLeaseLiability	186631	usd
CY2022Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	250000	usd
CY2022Q2	cbnt	Net Proceeds NetProceeds	250000	usd
CY2022Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.06	pure
CY2022Q2	us-gaap	Debt Conversion Original Debt Due Date Of Debt Day Month And Year DebtConversionOriginalDebtDueDateOfDebtDayMonthAndYear	2024-05-02
	cbnt	Interest Expenses InterestExpenses	5663	usd
CY2023Q2	cbnt	Company Repaid Amount CompanyRepaidAmount	200000	usd
CY2023Q2	cbnt	Accruedinterest Payabless AccruedinterestPayabless	50000	usd
CY2023Q2	cbnt	Related Party Amount RelatedPartyAmount	15690	usd
CY2023Q2	cbnt	Due To Related Parties Currents DueToRelatedPartiesCurrents	250000	usd
CY2023Q2	cbnt	Accrued Interest Payable AccruedInterestPayable	10027	usd
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	4000000	usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	1989755	usd
CY2023Q2	cbnt	Principal Balance PrincipalBalance	400000	usd
CY2023Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	310192	usd
CY2023Q2	us-gaap	Cash Cash	200000	usd
CY2023Q2	us-gaap	Shares Issued SharesIssued	22000000	shares
CY2022Q2	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	419260	usd
CY2022Q3	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	419260	usd
CY2022Q3	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	419260	usd
CY2022Q1	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	271825	usd
CY2022Q4	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	271825	usd
CY2021Q2	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	875000	usd
CY2022Q4	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	875000	usd
CY2023Q2	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	875000	usd
CY2022Q4	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	288035	usd
CY2022Q4	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	288035	usd
CY2023Q1	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	288035	usd
CY2023Q2	cbnt	Sale Of Product saleOfProduct	4051709	usd
CY2023Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent		usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2023Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable		usd
	us-gaap	Paid In Kind Interest PaidInKindInterest		usd
	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives		usd
	us-gaap	Increase Decrease In Due To Other Related Parties IncreaseDecreaseInDueToOtherRelatedParties		usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	cbnt	Common Stock Issued For Accrued Compensation CommonStockIssuedForAccruedCompensation		usd
	cbnt	Deemed Dividend Related To Ratchet Provision DeemedDividendRelatedToRatchetProvision		usd
	cbnt	Increase In Debt Discount And Paidin Capital For Shares Issued With Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForSharesIssuedWithConvertibleDebt		usd
	cbnt	Increase In Debt Discount And Paidin Capital For Warrants Issued With Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForWarrantsIssuedWithConvertibleDebt		usd
	cbnt	Increase In Debt Discount And Paidin Capital For Beneficial Conversion Feature On Convertible Debt IncreaseInDebtDiscountAndPaidinCapitalForBeneficialConversionFeatureOnConvertibleDebt		usd
	cbnt	Conversion Of Notes Payable To Common Stock ConversionOfNotesPayableToCommonStock		usd
	cbnt	Common Stock Issued For Accouts Payable CommonStockIssuedForAccoutsPayable		usd
CY2022Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock		usd
	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock		usd
CY2022Q2	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax		usd
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax		usd
CY2022Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion		shares
CY2022Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion		shares
CY2022Q2	cbnt	Series B Preferred Shares SeriesBPreferredShares		shares
CY2022Q2	cbnt	Series B Preferred Shares SeriesBPreferredShares		shares
CY2022Q2	cbnt	Series C Preferred Shares SeriesCPreferredShares		shares
CY2022Q2	cbnt	Series C Preferred Shares SeriesCPreferredShares		shares
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials		usd
CY2023Q2	us-gaap	Inventory Adjustments InventoryAdjustments		usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments		usd
CY2023Q2	us-gaap	Intermediate Life Plants Useful Life IntermediateLifePlantsUsefulLife
	cbnt	Goodwill Useful Life GoodwillUsefulLife
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2023Q2	cbnt	Add Put Premium AddPutPremium		usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent		usd
	cbnt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Grants Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsGrantsNumberOfShares		shares
	cbnt	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Granted Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsGrantedWeightedAverageGrantDateFairValue
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001421636

Files In Submission

Name	View Source	Status
cbnt-20230630_lab.xml	Edgar Link	unprocessable
cbnt-20230630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cbnt-20230630_def.xml	Edgar Link	unprocessable
cbnt-20230630_pre.xml	Edgar Link	unprocessable
0001213900-23-066976-index-headers.html	Edgar Link	pending
0001213900-23-066976-index.html	Edgar Link	pending
0001213900-23-066976.txt	Edgar Link	pending
0001213900-23-066976-xbrl.zip	Edgar Link	pending
cbnt-20230630.xsd	Edgar Link	pending
f10q0623ex31-1_cbondsys.htm	Edgar Link	pending
f10q0623ex31-2_cbondsys.htm	Edgar Link	pending
f10q0623ex32-1_cbondsys.htm	Edgar Link	pending
f10q0623_cbondsys.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
f10q0623_cbondsys_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CBNT
C-Bond Systems, Inc Stock $cbnt

2023 Q3 Form 10-Q Financial Statement

#000121390023066976 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBNT C-Bond Systems, Inc Stock $cbnt

2023 Q3 Form 10-Q Financial Statement

#000121390023066976 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CBNT
C-Bond Systems, Inc Stock $cbnt